Postmarket Transformation Plan Update With FDA’s Don St. Pierre
FDA's device center set out on an ambitious path last year to revamp the way it oversees product safety in what it is calling its 1"postmarket transformation" initiative
FDA's device center set out on an ambitious path last year to revamp the way it oversees product safety in what it is calling its 1"postmarket transformation" initiative